Original source: Biteye
There was Pump.fun, which made tens of millions of dollars a day, and now there is Four.Meme, where CZ calls orders. The casino effect of the on-chain launch platform is still hot. On February 8, the long-dormant DeSci (decentralized science) track also ushered in the news that the old project Pump.Science will launch a new launch platform next week. As soon as the news came out, $Rif and $Uro rebounded by 20%. Previously, Pump.Science co-founder Benjels said in an interview that 20 new compound tokens would be launched on Christmas Day in 2024.
However, in fact, he postponed this action until now. Within three months, with the influence of external factors such as interest rate cuts, the official tokens of Pump.Science, $Rif and $Uro, fell by more than 95% from the market value highs of 240m and 140m, respectively. During the same period, the market value of DeScis financial layer project BIO also fell by about 90% from its high point after it was launched on Binance. The DeSci track, which was called by CZ and Vitalik, is full of grief. It seems that this new narrative that was highly expected to further achieve mass adoption has been called down by everyone.
Will the new launch platform set off a wave of DeScis revival?
According to the official document of the Pump.Science community, the process of the new launch platform is:
① A user lists a compound together with a token in the Pump.Science platform.
② Users can buy and sell tokens on the Bonding Curve with the same parameters as Pump.fun to support the research of this compound. 79% of the tokens are issued along the Bonding Curve. When the token market value reaches 303 Sol (of which 85 Sol are in circulation), the Bonding Curve is closed. The liquidity of 82 Sol will be migrated to Meteora for trading. 3 Sol is used to pay for the corresponding worm experiment fees.
Of particular note is that the Pump.Science new launch platform will implement a dynamic fee structure to discourage sniping robots and prevent automated exploits during the initial token sale. Specific measures include:
① Bot Deterrence: Dynamic fee structure is specifically designed to reduce front-running by sniper bots.
② Early Risk: The fees for the first 150 slots (about 2 min) are extremely high (99.99%), which will severely reduce the number of tokens received by buyers.
③Monitoring activity: Between 150-250 slots (2-4 min), the cost will drop rapidly.
Dynamic Fee Structure Curve:
The white paper also states that all new compounds need to be airdropped to the builders and holders of $Rif and $Uro. There is no doubt that Pump.Sciences opening of a new token launch platform is a massive self-rescue. The weak DeSci track urgently needs new attention hotspots and the emergence of wealth-creating effects. Today, the hunters on the Sol chain have been lost in the numerous AI Agents and celebrity coins for too long and are exhausted physically and mentally, and the BSC chain has seen CZs open call for diversion. Can the crisis-ridden chain rekindle the DeSci craze like Rif and Uro to open up the situation? Can the addition of new compounds, new Dev, and new attention increments activate more DeSci gameplay to attract fresh water? Three months after the DeSci project was launched, it has indeed come to a critical juncture to determine whether DeSci will be revived or depressed.
90% refund for oversubscription, $Pain-style pre-sale of new compound EGS full pattern aroused heated discussion
At 3:19 am on February 9, Pump.Science’s official Twitter account commented on its upcoming compound project $EGS @EGCGxSFN, saying, “Earning trust is the most admirable thing.” Looking through Twitter, it can be found that Pump.Science’s new compound project $EGS unexpectedly opened a 24-hour pre-sale window on the morning of February 7. According to on-chain data, the pre-sale wallet address of $EGS finally raised 1,223 Sols before block height 319172095. Even more striking is that the project party tweeted that it would refund 91.87% of the raised funds, leaving only 100 Sol for token launch and liquidity support. This pre-sale “over-raising and high-refund” strategy is similar to the previously popular $pain project, but EGS’s refund behavior and refund ratio have both set a precedent for the DeSci project. The EGS project team announced on Twitter, In 24 hours, there was no marketing, no whales, and we proved our trust in science. They also announced that EGS will open at a market value of 100k as a gift to DeScis diamond holders, and that the effective pre-sale payments have already generated about three times the profit.
EGS is the abbreviation of the compounds Epigallocatechin Gallate and Sulforaphane. EGCG is the core active ingredient in green tea and is known as the king of antioxidants. It inhibits cell aging by activating the AMPK pathway and removes free radicals to reduce oxidative damage. Studies have shown that EGCG can extend the lifespan of model organisms such as nematodes and fruit flies by up to 20%. Its mechanisms include inhibiting pro-inflammatory factors, enhancing mitochondrial function, and possibly delaying telomere shortening through epigenetic regulation. Sulforaphane is derived from the cell guard of cruciferous vegetables such as broccoli, and significantly improves the antioxidant capacity of cells by activating the Nrf 2 pathway. Experiments have confirmed that Sulforaphane can extend the lifespan of mice by about 15%. Its key roles include promoting autophagy to clear senescent cells, repairing DNA damage, and inhibiting chronic inflammation associated with aging (such as the NF-κB pathway). Both of them delay aging through multi-target synergy and are a few longevity candidate molecules with clinical transformation potential among natural compounds.
Obviously, the new compound inherits the previous IP monetization logic of Rif and Uro, and reduces the risk through high pre-sale refunds. This is the low threshold and high odds story that DeSci urgently needs. However, can such a topic-rich pre-sale gameplay, combined with DeScis trust science narrative, align Rif and Uro after the launch of the new platform? The answer is uncertain. Benjels, co-founder of Pump.Science, admitted that DeScis problem is that the narrative is grand, but it is difficult to land. Users want to support science and hope to obtain speculative returns. How to balance the two is the key. In todays market where pulling the market is justice, the grand narrative of a single decentralized science has been proven to be unacceptable to the market. The road to the revival of the DeSci track is still a long way to go, and more eye-catching gameplay is urgently needed to grab the sensitive attention of the circle. I just hope that this time, Pump.Sciences new compounds can bring new growth to the devastated DeSci track, and as promised in the tweet, can bring both financial and spiritual comfort to those DeSci diamond hands who are still persisting.
Appendix: List of new compounds from Pump.Science
-Punicalagin Berberine: Pomegranate polyphenols, which have strong antioxidant and anti-inflammatory effects; Berberine: AMPK activator, which can regulate blood sugar and improve metabolic health. Together, pomegranate polyphenols support cardiovascular health and anti-inflammatory pathways, which can complement the metabolic effects of berberine.
- Resveratrol Berberine: Resveratrol, a polyphenol, activates sirtuins, improves mitochondrial efficiency, and mimics the effects of calorie restriction; Berberine: an AMPK activator that regulates blood sugar and improves metabolic health. Together, both resveratrol and berberine activate AMPK and sirtuins, potentially leading to longevity, metabolic control, and enhanced cellular repair.
-Ginsenoside Rh 2 : Ginsenoside Rh 2 , a bioactive compound in ginseng, has anti-cancer, neuroprotective and anti-inflammatory effects.
-Aspalathin Caffeine: Aspalathin, the bioactive flavonoid in Rooibos tea, has antioxidant and blood sugar lowering effects; caffeine, a stimulant, improves mental and physical energy. Together, aspalathin can offset the potential negative effects of caffeine on blood sugar and stress hormones, providing a more balanced stimulant response.
- Gossypol Catechin Hydrat: Gossypol, a polyphenol with potential anti-cancer and metabolic effects; Catechin Hydrat, a catechin similar to EGCG with strong antioxidant properties. Together, these two compounds can modulate cellular stress responses and improve metabolic efficiency.
-Biotin Berberine: Biotin, a substance necessary for fatty acid metabolism, glucose regulation and skin health; berberine, a metabolic regulator, can improve insulin sensitivity. In synergy, biotin can complement the effects of berberine by improving lipid metabolism and enhancing mitochondrial function.
-Urolithin A EGCG: Urolithin A, a metabolite extracted from pomegranates, promotes mitophagy (recycling of damaged mitochondria); EGCG, a green tea catechin, has strong antioxidant and anti-inflammatory effects. Together, EGCG and urolithin A support mitochondrial function and longevity pathways, potentially improving cellular energy efficiency.
-Berberine Quercetin: Berberine, a metabolic regulator, improves insulin sensitivity, lowers blood sugar, and supports cardiovascular health; quercetin, a flavonoid with anti-inflammatory, antioxidant, and antiviral properties, promotes nutrient absorption. Working synergistically, quercetin can increase the bioavailability of berberine while also complementing its metabolic effects, thereby improving glucose regulation and mitochondrial function.
-Hesperidin DHM (Dihydromyricetin): Hesperidin, a flavonoid found in citrus, improves circulation, reduces oxidative stress, and supports vascular health; DHM (Dihydromyricetin), for liver protection, alcohol metabolism support, and neuroprotection. Both compounds modulate liver enzymes and inflammatory pathways, thereby enhancing detoxification and metabolic recovery.
-EGCG: Green tea catechins, which have strong antioxidant and anti-inflammatory effects.
-Caffeine: Caffeine is a stimulant that increases energy, cognitive function, and endurance. It detoxifies the liver and reduces premature death.
-Artemisinin: Artemisinin, extracted from sweet wormwood, has anti-malarial, anti-cancer and anti-inflammatory properties.
Recently, as Binance Research once again published an article affirming the DeSci track, BIO, Rif and Uro have all risen by 20%. It seems that the DeSci trend is about to blow again. At the same time, these compounds will also be launched on the new Pump.Science platform. With such a wide range of tokens being launched, everyone needs to continue to pay attention to the high-quality tokens and select projects that are serious about work and those that are good at making things up, DYOR!
